UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.
Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patients.
UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.
It’s been more than a year since our news feeds first alerted us to a mysterious illness and its rapid spread. Since then, the COVID-19 pandemic has transformed our lives and touched every part of the globe.
The first photo in Paige Nguyen’s pandemic diary is full of complexities. As a first-year student, Nguyen has yet to experience a full campus teeming with activity, but one assignment in her History of Public Health class— the term project “Diaries in the time of Plague”—brought this moment…
Sally Ride is remembered as the first American woman in space and as a champion of diversity and equity in science education. To mark the 20th anniversary of the founding of Sally Ride Science, here are 20 things you might not know about her.
After America’s first woman in space retired from NASA, Sally Ride preferred to keep a low profile. The in 2001, while teaching physics at UC San Diego, she decided the time was right to use her famous name for a cause she cared about, cofounding a company called Sally Ride Science.